Harrow Inc (HROW)
10.38
-0.26
(-2.44%)
USD |
NASDAQ |
May 03, 16:00
10.38
0.00 (0.00%)
After-Hours: 20:00
Harrow Market Cap: 367.06M for May 3, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| May 03, 2024 | 367.06M |
| May 02, 2024 | 376.26M |
| May 01, 2024 | 368.83M |
| April 30, 2024 | 360.34M |
| April 29, 2024 | 375.55M |
| April 26, 2024 | 372.37M |
| April 25, 2024 | 353.63M |
| April 24, 2024 | 363.17M |
| April 23, 2024 | 364.94M |
| April 22, 2024 | 374.84M |
| April 19, 2024 | 369.54M |
| April 18, 2024 | 383.68M |
| April 17, 2024 | 417.99M |
| April 16, 2024 | 434.96M |
| April 15, 2024 | 436.73M |
| April 12, 2024 | 447.34M |
| April 11, 2024 | 466.43M |
| April 10, 2024 | 457.24M |
| April 09, 2024 | 467.14M |
| April 08, 2024 | 467.14M |
| April 05, 2024 | 477.75M |
| April 04, 2024 | 465.02M |
| April 03, 2024 | 463.25M |
| April 02, 2024 | 437.79M |
| April 01, 2024 | 452.64M |
| Date | Value |
|---|---|
| March 28, 2024 | 467.85M |
| March 27, 2024 | 450.17M |
| March 26, 2024 | 444.86M |
| March 25, 2024 | 424.35M |
| March 22, 2024 | 406.67M |
| March 21, 2024 | 374.14M |
| March 20, 2024 | 372.01M |
| March 19, 2024 | 376.61M |
| March 18, 2024 | 370.95M |
| March 15, 2024 | 368.92M |
| March 14, 2024 | 358.01M |
| March 13, 2024 | 372.08M |
| March 12, 2024 | 367.86M |
| March 11, 2024 | 370.67M |
| March 08, 2024 | 385.09M |
| March 07, 2024 | 400.57M |
| March 06, 2024 | 397.75M |
| March 05, 2024 | 390.02M |
| March 04, 2024 | 394.24M |
| March 01, 2024 | 385.09M |
| February 29, 2024 | 380.70M |
| February 28, 2024 | 384.74M |
| February 27, 2024 | 411.47M |
| February 26, 2024 | 396.35M |
| February 23, 2024 | 384.74M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
89.34M
Minimum
Mar 23 2020
845.83M
Maximum
May 09 2023
278.23M
Average
217.59M
Median
Jan 21 2021
Market Cap Benchmarks
| Aquestive Therapeutics Inc | 258.02M |
| Cyclacel Pharmaceuticals Inc | 2.637M |
| Lifecore Biomedical Inc | 195.19M |
| Relmada Therapeutics Inc | 111.04M |
| Corvus Pharmaceuticals Inc | 94.15M |
Market Cap Related Metrics
| PS Ratio | 2.599 |
| PEG Ratio | -0.2959 |
| Price to Book Value | 5.187 |
| Price | 10.38 |
| Earnings Yield | -7.32% |
| PEGY Ratio | -0.2959 |
| Operating PE Ratio | 417.25 |